Memantine/donepezil ER 21mg/10mg CP
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your dose in the evening, with or without food. Swallow the capsule whole - do not chew or crush it. If you notice any capsules that appear abnormal or are damaged, do not take them.
If you have difficulty swallowing the capsule whole, you can sprinkle its contents onto applesauce. If you choose to do this, swallow the mixture immediately without chewing.
Continue taking your medication as directed by your doctor or healthcare provider, even if you start feeling well.
Storing and Disposing of Your Medication
Keep your medication at room temperature in a dry location, avoiding storage in a bathroom. Store it in its original container or in a container that protects it from light.
What to Do If You Miss a Dose
If you miss a dose, skip it and resume your normal dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take this medication once daily, usually in the evening, with or without food.
- Swallow the capsule whole. Do not crush, chew, or divide the capsule.
- If you have difficulty swallowing, the capsule may be opened and the entire contents sprinkled on a small amount of applesauce. Swallow the mixture immediately without chewing.
- Take the medication at the same time each day to help you remember.
- Do not stop taking this medication suddenly without consulting your doctor, as it may worsen symptoms.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Urination problems
Severe dizziness or fainting
Fever, chills, or sore throat
New or worsening breathing difficulties
Seizures
Stomach pain or heartburn
Black, tarry, or bloody stools
Vomiting blood or coffee ground-like material
Slow heartbeat
Abnormal heartbeat
Bruising
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:
Diarrhea
Upset stomach or vomiting
Decreased appetite
Dizziness or headache
Muscle cramps
Fatigue or weakness
* Sleep disturbances
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Severe or persistent nausea, vomiting, or diarrhea
- Slow or irregular heartbeat (bradycardia)
- Fainting spells or severe dizziness
- Seizures
- Severe confusion or agitation
- Unusual muscle weakness or cramps
- Dark-colored urine (rhabdomyolysis, rare)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your current medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Severe cholinergic symptoms (e.g., severe nausea, vomiting, salivation, sweating, bradycardia, hypotension, collapse, convulsions)
- Severe CNS effects (e.g., agitation, hallucinations, stupor, coma)
- Severe dizziness
- Lethargy
- Vertigo
- Ataxia
- Vomiting
- Diarrhea
What to Do:
Seek immediate medical attention. Call 911 or your local poison control center (1-800-222-1222 in the US). Treatment is supportive. Atropine may be used for cholinergic crisis. Dialysis may be considered for memantine overdose.
Drug Interactions
Major Interactions
- Other NMDA antagonists (e.g., amantadine, ketamine, dextromethorphan) - increased risk of CNS toxicity.
- Cholinomimetics (e.g., bethanechol, succinylcholine) - increased cholinergic effects.
Moderate Interactions
- Drugs that increase urine pH (e.g., carbonic anhydrase inhibitors, sodium bicarbonate) - decreased memantine renal clearance.
- CYP3A4/2D6 inhibitors (e.g., ketoconazole, quinidine, fluoxetine, paroxetine) - may increase donepezil levels.
- CYP3A4/2D6 inducers (e.g., rifampin, phenytoin, carbamazepine, phenobarbital) - may decrease donepezil levels.
- Anticholinergics (e.g., atropine, scopolamine) - antagonistic effects with donepezil.
- Beta-blockers - increased risk of bradycardia with donepezil.
Minor Interactions
- Cimetidine, ranitidine, quinidine, nicotine - may increase memantine levels by inhibiting renal tubular secretion.
- Hydrochlorothiazide - may decrease memantine levels.
Monitoring
Baseline Monitoring
Rationale: To establish baseline cognitive status and monitor disease progression/response to therapy.
Timing: Prior to initiation of therapy
Rationale: Donepezil can cause bradycardia and syncope.
Timing: Prior to initiation of therapy
Rationale: Consider for patients with pre-existing cardiac conduction abnormalities or those at risk for bradycardia (due to donepezil).
Timing: Prior to initiation of therapy (if indicated)
Routine Monitoring
Frequency: Every 6-12 months or as clinically indicated
Target: Improvement or stabilization of cognitive scores
Action Threshold: Significant decline may warrant re-evaluation of therapy.
Frequency: Regularly, especially during titration and dose changes
Target: Minimization of side effects
Action Threshold: Persistent or severe adverse effects may require dose reduction or discontinuation.
Frequency: Periodically, or if symptoms of bradycardia/hypotension occur
Target: Within normal limits for the patient
Action Threshold: Significant bradycardia or hypotension may require intervention.
Symptom Monitoring
- Nausea
- Vomiting
- Diarrhea
- Dizziness
- Headache
- Confusion
- Agitation
- Hallucinations
- Bradycardia (slow heart rate)
- Syncope (fainting)
- Muscle cramps
- Fatigue
Special Patient Groups
Pregnancy
Category C. There are no adequate and well-controlled studies of Memantine/donepezil in pregnant women. Use only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
It is not known whether memantine or donepezil are excreted in human milk. Donepezil is excreted in the milk of rats. Caution should be exercised when administered to a nursing mother.
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. This drug is not indicated for use in pediatric populations.
Geriatric Use
Alzheimer's disease primarily affects the geriatric population. No specific dose adjustment is generally required based on age alone, but elderly patients may be more susceptible to adverse effects (e.g., bradycardia, syncope, GI upset) and should be monitored closely.
Clinical Information
Clinical Pearls
- Memantine/donepezil ER is a fixed-dose combination indicated for the treatment of moderate to severe Alzheimer's disease in patients already stabilized on donepezil 10 mg.
- The extended-release formulation allows for once-daily dosing, which may improve patient adherence and reduce peak-related side effects compared to immediate-release formulations.
- Capsules can be opened and sprinkled on applesauce for patients with swallowing difficulties, but the beads must not be chewed.
- Titration is crucial to minimize gastrointestinal side effects (nausea, vomiting, diarrhea) and other adverse events like dizziness and bradycardia.
- Monitor for signs of bradycardia or syncope, especially in patients with pre-existing cardiac conditions.
- This medication treats symptoms but does not cure Alzheimer's disease or stop its progression.
Alternative Therapies
- Other cholinesterase inhibitors (e.g., rivastigmine, galantamine)
- Other NMDA receptor antagonists (no other approved for AD)